Ratings by Noble Capital (Robert LeBoyer)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2026 | Ocugen, Inc. | OCGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/5/2026 | Cardiff Oncology | CRDF | New Coverage | Outperform (N/A) |
2.66 (1.27) |
-52.26% | Details | |
| 8/20/2025 | Greenwich LifeSciences | GLSI | New Coverage | Outperform (N/A) |
11.47 (23.25) |
102.7% | Details | |
| 7/23/2025 | The Oncology Insititute Inc. | TOI | New Coverage | Outperform (N/A) |
3.54 (5.60) |
58.19% | Details | |
| 3/25/2025 | Tonix Pharma | TNXP | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2024 | Zomedica | ZOM | New Coverage | Outperform (N/A) |
0.12 (0.10) |
-16.67% | Details | |
| 8/19/2024 | GeoVax Labs Inc. | GOVX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2024 | Cocrystal Pharma | COCP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/14/2024 | Unicycive Therapeutics | UNCY | Maintain | Outperform (N/A) |
|
Details | ||
| 4/11/2024 | Tonix Pharma | TNXP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2024 | Unicycive Therapeutics | UNCY | New Coverage | Outperform (N/A) |
1.05 (7.70) |
633.33% | Details | |
| 2/12/2024 | Ocugen, Inc. | OCGN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/18/2023 | Cadrenal Therapeutics | CVKD | New Coverage | Outperform (N/A) |
0.51 (3.02) |
492.16% | Details | |
| 5/8/2023 | GeoVax Labs Inc. | GOVX | New Coverage | Outperform (N/A) |
0.63 (1.28) |
103.17% | Details | |
| 2/21/2023 | MAIA Biotechnology | MAIA | New Coverage | Outperform (N/A) |
4.53 (1.48) |
-67.33% | Details | |
| 12/16/2022 | Axcella Health Inc. | AXLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/28/2022 | PDS Biotechnology Corp | PDSB | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2022 | Ocugen, Inc. | OCGN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/23/2022 | Tonix Pharma | TNXP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/24/2022 | Tonix Pharma | TNXP | Maintain | Outperform (N/A) |
|
Details | ||
| 4/18/2022 | Tonix Pharma | TNXP | New Coverage | Outperform (N/A) |
0.19 (12.75) |
6610.53% | Details | |
| 10/12/2021 | Axcella Health Inc. | AXLA | New Coverage | Outperform (N/A) |
2.84 (4.58) |
61.27% | Details | |
| 8/19/2021 | Lineage Cell Therapeutics Inc. | LCTX | New Coverage | Outperform (N/A) |
2.42 (1.35) |
-44.21% | Details | |
| 7/26/2021 | Ocugen, Inc. | OCGN | New Coverage | (N/A) |
6.94 (1.68) |
-75.79% | Details | |
| 5/27/2021 | Cocrystal Pharma Inc | COCP | New Coverage | Outperform (N/A) |
1.16 (1.03) |
-11.21% | Details |
